{
    "root": "349e2ce2-f399-926c-e063-6294a90a9185",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Indomethacin",
    "value": "20250508",
    "ingredients": [
        {
            "name": "SUCROSE",
            "code": "C151H8M554",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17992"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11061"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "POTASSIUM CATION",
            "code": "295O53K152",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_36916"
        },
        {
            "name": "INDOMETHACIN",
            "code": "XXE1CET956",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00328"
        }
    ],
    "indications": {
        "text": "indomethacin extended-release capsules indicated : \u2022 moderate severe rheumatoid arthritis including acute flares chronic disease \u2022 moderate severe ankylosing spondylitis \u2022 moderate severe osteoarthritis \u2022 acute painful shoulder ( bursitis and/or tendinitis )",
        "doid_entities": [
            {
                "text": "rheumatoid arthritis (DOID:7148)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7148"
            },
            {
                "text": "arthritis (DOID:848)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_848"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "ankylosing spondylitis (DOID:7147)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7147"
            },
            {
                "text": "spondylitis (DOID:6590)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6590"
            },
            {
                "text": "osteoarthritis (DOID:8398)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8398"
            },
            {
                "text": "bursitis (DOID:2965)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2965"
            },
            {
                "text": "tendinitis (DOID:971)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_971"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "severe rheumatoid arthritis",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_284130"
            },
            {
                "disease": "severe ankylosing spondylitis",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_825"
            }
        ]
    },
    "contraindications": {
        "text": "\u2022 lowest effective shortest duration consistent individual patient treatment goals ( 2.1 ) \u2022 moderate severe rheumatoid arthritis including acute flares chronic disease ; moderate severe ankylosing spondylitis ; moderate severe osteoarthritis one indomethacin extended-release 75 mg capsule daily ( 2.2 ) \u2022 acute painful shoulder ( bursitis and/or tendinitis ) one indomethacin extended-release 75 mg capsule twice daily ( 2.3 )",
        "doid_entities": [
            {
                "text": "rheumatoid arthritis (DOID:7148)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7148"
            },
            {
                "text": "arthritis (DOID:848)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_848"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "ankylosing spondylitis (DOID:7147)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7147"
            },
            {
                "text": "spondylitis (DOID:6590)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6590"
            },
            {
                "text": "osteoarthritis (DOID:8398)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8398"
            },
            {
                "text": "bursitis (DOID:2965)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2965"
            },
            {
                "text": "tendinitis (DOID:971)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_971"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "severe rheumatoid arthritis",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_284130"
            },
            {
                "disease": "severe ankylosing spondylitis",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_825"
            },
            {
                "disease": "severe osteoarthritis one",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_284984"
            }
        ]
    },
    "warningsAndPrecautions": "indomethacin extended-release capsules usp , 75 mg size \u2018 2 \u2019 , dark yellow cap clear transparent body hard gelatin capsules , containing cream spherical pellets imprinted \u2018 h \u2019 cap \u2018 105 \u2019 body . supplied bottles 30 capsules ndc 31722-565-30 bottles 60 capsules ndc 31722-565-60 bottles 100 capsules ndc 31722-565-01 bottles 500 capsules ndc 31722-565-05 bottles 1000 capsules ndc 31722-565-10 storage store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . protect moisture",
    "adverseReactions": "indomethacin extended-release capsules contraindicated following patients : \u2022 known hypersensitivity ( e.g . , anaphylactic serious skin ) indomethacin components product [ ( 5.7 , 5.9 ) ] \u2022 history asthma , urticaria , allergic-type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids reported patients [ ( 5.7 , 5.8 ) ] \u2022 setting coronary artery bypass graft ( cabg ) surgery [ ( 5.1 ) ]",
    "indications_original": "Indomethacin extended-release capsules are indicated for: \n    \u2022 Moderate to severe rheumatoid arthritis including acute flares of chronic disease \n    \u2022 Moderate to severe ankylosing spondylitis \n    \u2022 Moderate to severe osteoarthritis \n    \u2022 Acute painful shoulder (bursitis and/or tendinitis)",
    "contraindications_original": "\u2022 Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals ( 2.1 ) \u2022 The dosage for moderate to severe rheumatoid arthritis including acute flares of chronic disease; moderate to severe ankylosing spondylitis; and moderate to severe osteoarthritis is one indomethacin extended-release 75 mg capsule daily ( 2.2 ) \u2022 The dosage for acute painful shoulder (bursitis and/or tendinitis) is one indomethacin extended-release 75 mg capsule once or twice daily ( 2.3 )",
    "warningsAndPrecautions_original": "Indomethacin extended-release capsules USP, 75 mg are size \u20182\u2019, dark yellow cap and clear transparent body hard gelatin capsules, containing cream spherical pellets imprinted with \u2018H\u2019 on cap and \u2018105\u2019 on body. They are supplied as \n    Bottles of 30 capsules\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0NDC 31722-565-30 \n    Bottles of 60 capsules\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0NDC 31722-565-60 \n    Bottles of 100 capsules\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0NDC 31722-565-01 \n    Bottles of 500 capsules\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0NDC 31722-565-05 \n    Bottles of 1000 capsules\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0NDC 31722-565-10 \n  \n                     Storage\n                       Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature]. Protect from moisture",
    "adverseReactions_original": "Indomethacin extended-release capsules are contraindicated in the following patients: \n    \u2022 Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to indomethacin or any components of the drug product\n \n  [see\n  \n   Warnings and Precautions (5.7,\n  \n   5.9)]\n \n  \n                       \u2022 History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients\n \n  [see\n  \n   Warnings and Precautions (5.7,\n  \n   5.8)]\n \n  \n                       \u2022 In the setting of coronary artery bypass graft (CABG) surgery\n \n  [see\n  \n   Warnings and Precautions (5.1)]",
    "drug": [
        {
            "name": "Indomethacin",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00328"
        }
    ]
}